[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366963-105":59,"doc-detail-366963-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","aldoa-mediated-metabolic-reprogramming-is-a-targetable-vulnerability-for-ferroptosis-sensitization-in-cancer","ALDOA-Mediated Metabolic Reprogramming is a Targetable Vulnerability for Ferroptosis Sensitization in Cancer","","Ferroptosis offers strong therapeutic potential in cancer, but conventional approaches that suppress canonical ferroptosis inhibitors often trigger ferroptosis in both cancer and normal cells, limiting efficacy. This study shows that aldolase A (ALDOA) reprograms lipid metabolism to protect cancer cells and defines ALDOA as a targetable vulnerability for sensitization to ferroptosis. ALDOA suppression increases ferroptosis susceptibility in cancer cells, linked to fructose 1,6-bisphosphate accumulation, autophagy-dependent degradation of phospholipid-modifying enzymes, and a shift toward pro-ferroptotic phospholipids. ALDOA inhibitors promote ferroptosis selectively in vitro and in vivo.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/aldoa-mediated-metabolic-reprogramming-is-a-targetable-vulnerability-for-ferroptosis-sensitization-in-cancer/366963/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/aldoa-mediated-metabolic-reprogramming-is-a-targetable-vulnerability-for-ferroptosis-sensitization-in-cancer/366963.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is ferroptosis induction challenging for cancer therapy?","Question",{"text":113,"@type":114},"Suppressing canonical ferroptosis inhibitors can induce ferroptosis non-selectively in both cancerous and normal cells, restricting therapeutic potential.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does ALDOA play in ferroptosis sensitivity?",{"text":118,"@type":114},"ALDOA reprograms lipid metabolism to resist ferroptosis in cancer cells, and ALDOA suppression increases cancer cell susceptibility.",{"name":120,"@type":111,"acceptedAnswer":121},"How does ALDOA depletion enhance ferroptosis in cancer cells?",{"text":122,"@type":114},"ALDOA depletion leads to fructose 1,6-bisphosphate accumulation and promotes autophagy-dependent degradation of phospholipid-modifying enzymes, shifting the phospholipid composition toward pro-ferroptotic polyunsaturated fatty acids.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366963,1790315923,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nALDOA-Mediated Metabolic Reprogramming is a Targetable Vulnerability for Ferroptosis Sensitization in Cancer  \nPengqi Wang, Kezhang He, Bowen Wang, Wei Zhou, Ying Zhang, Tianhua Ma,* and Sheng Ding*  \nFerroptosis presents great potential for cancer therapy, either alone or in combination with classical therapy. However, inducing ferroptosis by targeting canonical ferroptosis suppressors that directly inhibit lipid peroxidation non-selectively induces ferroptosis in both cancerous and normal cells, thereby limiting its therapeutic potential. In this study, it is revealed that aldolase A (ALDOA) reprograms lipid metabolism to resist ferroptosis in cancer cells and identiﬁes ALDOA as a targetable vulnerability for ferroptosis sensitization. Cancer cells with ALDOA suppression exhibit increased susceptibility to ferroptosis—a response less obvious in normal cells. Mechanistically, ALDOA depletion induces signiﬁcant accumulation of fructose 1,6-bisphosphate in cancer cells, thereby enhancing  \nautophagy-dependent degradation of phospholipid-modifying enzymes. These alterations increase the ratio of phospholipids containing pro-ferroptotic polyunsaturated fatty acids over anti-ferroptotic monounsaturated fatty acids, culminating in heightened ferroptosis sensitivity. Moreover, ALDOA inhibitors selectively promote ferroptosis in cancer cells, both in vitro and in vivo. Collectively, the ﬁndings reveal that ALDOA-mediated metabolic reprogramming is a targetable vulnerability for ferroptosis sensitization in cancer.  \n1. Introduction  \nFerroptosis, a form of regulated cell death driven by the accumulation of toxic oxidized lipids, has been implicated across a wide range of diseases,[1] including cancer,[2–4] neurodegenerative disorders,[5,6] as well as organ ischemia-reperfusion injuries. [7,8] Notably, ferroptosis induction has shown great potential in cancer therapy by overcoming resistance to conventional therapies and complementing established modalities such as chemotherapy, immunotherapy, and radiotherapy.[3,4,9–12] However, concerns about its potential side eﬀects have been noted. [12,13] In fact, recent research has shown that various normal tissues are also susceptible to ferroptosis,[14] impeding the application of ferroptosis induction as a viable cancer therapeutic strategy. Indeed, the downregulation or inhibition of known ferroptosis suppressors, such as glutathione peroxidase 4 (GPX4),[15] ferroptosis suppressor protein 1 (FSP1),[16,17] dihydroorotate dehydrogenase  \nP. Wang, K. He, B. Wang, W. Zhou, T. Ma, S. Ding  \nNew Cornerstone Science Laboratory, School of Pharmaceutical Sciences Tsinghua University  \nBeijing 100084, China  \n[E-mail:](E-mail: matianhua@tsinghua.edu.cn)[ matianhua@tsinghua.edu.cn](E-mail: matianhua@tsinghua.edu.cn); [shengding@tsinghua.edu.cn](shengding@tsinghua.edu.cn)  \nY. Zhang  \nSchool of Life Sciences Tsinghua University Beijing 100084, China  \nS. Ding  \nTsinghua-Peking Joint Center for Life Sciences Tsinghua University  \nBeijing 100084, China  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202511880](https://doi.org/10.1002/advs.202511880)[ ](https://doi.org/10.1002/advs.202511880)© 2025 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202511880  \n(DHODH),[18] and 7-dehydrocholesterol (7-DHC) synthesis proteins,[19,20] promotes ferroptosis non-selectively in both cancerous and normal cells. This underscores the urgent need to identify ferroptosis vulnerabilities in cancer cells to overcome these limitations and enable eﬀective cancer therapies through ferroptosis induction.  \nAs ferroptosis has been recognized as a metabo","cbCaikfCzTqpqJD2","https://ap.wps.com/l/cbCaikfCzTqpqJD2","pdf",3991607,14,"English","# Introduction\n## Ferroptosis as a regulated cell death linked to metabolism\n## Limitations of non-selective ferroptosis suppression\n## Metabolic reprogramming and glycolysis in cancer\n## Aldolase (ALDOA) as a candidate vulnerability","[{\"question\":\"Why is ferroptosis induction challenging for cancer therapy?\",\"answer\":\"Suppressing canonical ferroptosis inhibitors can induce ferroptosis non-selectively in both cancerous and normal cells, restricting therapeutic potential.\"},{\"question\":\"What role does ALDOA play in ferroptosis sensitivity?\",\"answer\":\"ALDOA reprograms lipid metabolism to resist ferroptosis in cancer cells, and ALDOA suppression increases cancer cell susceptibility.\"},{\"question\":\"How does ALDOA depletion enhance ferroptosis in cancer cells?\",\"answer\":\"ALDOA depletion leads to fructose 1,6-bisphosphate accumulation and promotes autophagy-dependent degradation of phospholipid-modifying enzymes, shifting the phospholipid composition toward pro-ferroptotic polyunsaturated fatty acids.\"}]","ALDOA-Mediated Metabolic Reprogramming is a Targetable Vulnerability for Ferroptosis Sensitization in Cancer | PDF",1790168445,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7142c4b6387feda1592e7cdbc5301ca.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bfab73d0c4f4c156ceab5db38b86c9f.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79d57684e4d46d6ac9a3567bca3c2e2b.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45658d9af51ec0a6c09f085498ba4f72.webp",980,1287]